Jonathan Zung
2021
In 2021, Jonathan Zung earned a total compensation of $4.6M as Chief Development Officer at Evelo Biosciences.
Compensation breakdown
| Bonus | $110,000 |
|---|---|
| Non-Equity Incentive Plan | $141,100 |
| Option Awards | $3,679,560 |
| Salary | $415,000 |
| Stock Awards | $166,500 |
| Other | $47,177 |
| Total | $4,559,336 |
Zung received $3.7M in option awards, accounting for 81% of the total pay in 2021.
Zung also received $110K in bonus, $141.1K in non-equity incentive plan, $415K in salary, $166.5K in stock awards and $47.2K in other compensation.
Rankings
In 2021, Jonathan Zung's compensation ranked 2,908th out of 12,415 executives tracked by ExecPay. In other words, Zung earned more than 76.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,908 out of 12,415 | 77th |
Division Manufacturing | 1,159 out of 5,508 | 79th |
Major group Chemicals And Allied Products | 461 out of 2,378 | 81st |
Industry group Drugs | 405 out of 2,099 | 81st |
Industry Pharmaceutical Preparations | 272 out of 1,549 | 82nd |
Source: SEC filing on April 26, 2022.
Zung's colleagues
We found two more compensation records of executives who worked with Jonathan Zung at Evelo Biosciences in 2021.